CCEL
Cryo-Cell·AMEX
--
--(--)
--
--(--)
CCEL fundamentals
During Q4 2025, Cryo-Cell (CCEL) reported revenue of 7.84M, a YoY change of -2.26%. Net income was -3.82M, a YoY change of -105.06%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Dec 1, 2019 | Mar 1, 2020 | Jun 1, 2020 | Sep 1, 2020 | Dec 1, 2020 | Mar 1, 2021 | Jun 1, 2021 | Sep 1, 2021 | Dec 1, 2021 | Mar 1, 2022 | Jun 1, 2022 | Sep 1, 2022 | Dec 1, 2022 | Mar 1, 2023 | Jun 1, 2023 | Sep 1, 2023 | Dec 1, 2023 | Mar 1, 2024 | Jun 1, 2024 | Sep 1, 2024 | Dec 1, 2024 | Mar 1, 2025 | Jun 1, 2025 | Sep 1, 2025 | -- |
End Date | Feb 29, 2020 | May 31, 2020 | Aug 31, 2020 | Nov 30, 2020 | Feb 28, 2021 | May 31, 2021 | Aug 31, 2021 | Nov 30, 2021 | Feb 28, 2022 | May 31, 2022 | Aug 31, 2022 | Nov 30, 2022 | Feb 28, 2023 | May 31, 2023 | Aug 31, 2023 | Nov 30, 2023 | Feb 29, 2024 | May 31, 2024 | Aug 31, 2024 | Nov 30, 2024 | Feb 28, 2025 | May 31, 2025 | Aug 31, 2025 | Nov 30, 2025 | -- |
Fiscal Year-End | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | Nov 30 | -- |
Revenue | 7.62M -- | 7.87M -- | 8.11M -- | 7.54M -- | 6.86M -9.97% | 7.21M -8.47% | 7.50M -7.53% | 7.32M -2.99% | 7.26M +5.80% | 7.63M +5.94% | 7.68M +2.36% | 7.76M +6.13% | 7.82M +7.80% | 7.77M +1.83% | 7.87M +2.46% | 7.88M +1.45% | 7.85M +0.36% | 8.04M +3.48% | 8.07M +2.50% | 8.02M +1.87% | 7.97M +1.49% | 7.93M -1.42% | 7.83M -2.99% | 7.84M -2.26% | 31.57M -- |
Sales and Services Revenue | 7.62M -- | 7.87M -- | 8.11M -- | 7.54M -- | 6.86M -9.97% | 7.21M -8.47% | 7.50M -7.53% | 7.32M -2.99% | 7.26M +5.80% | 7.63M +5.94% | 7.68M +2.36% | 7.76M +6.13% | 7.82M +7.80% | 7.77M +1.83% | 7.87M +2.46% | 7.88M +1.45% | 7.85M +0.36% | 8.04M +3.48% | 8.07M +2.50% | 8.02M +1.87% | 7.97M +1.49% | 7.93M -1.42% | 7.83M -2.99% | 7.84M -2.26% | 31.57M -- |
Cost of Revenue | 2.50M -- | 2.48M -- | 2.36M -- | 2.31M -- | 2.01M -19.61% | 2.22M -10.40% | 2.46M +4.18% | 2.30M -0.76% | 2.10M +4.52% | 2.20M -0.95% | 2.35M -4.48% | 2.14M -6.84% | 2.07M -1.70% | 2.14M -2.65% | 2.16M -8.20% | 2.02M -5.38% | 2.07M -0.05% | 2.02M -5.53% | 2.13M -1.41% | 1.64M -19.13% | 1.98M -3.96% | 1.86M -8.31% | 1.80M -15.26% | 1.73M +5.95% | 7.38M -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | 9.66M -- | -- -- | -- -- | -- -- | 8.99M -6.91% | -- -- | -- -- | -- -- | 8.79M -2.20% | -- -- | -- -- | 2.16M -- | 2.02M -76.98% | 2.07M -- | 2.02M -- | 2.13M -1.41% | 1.64M -19.13% | 1.98M -3.96% | 1.86M -8.31% | 1.80M -15.26% | 1.73M +5.95% | 7.38M -- |
Gross Profit | 5.12M -- | 5.39M -- | 5.75M -- | 5.23M -- | 4.85M -5.26% | 4.98M -7.58% | 5.04M -12.33% | 5.02M -3.97% | 5.16M +6.33% | 5.43M +9.01% | 5.33M +5.70% | 5.63M +12.07% | 5.76M +11.67% | 5.63M +3.64% | 5.71M +7.15% | 5.85M +4.05% | 5.79M +0.50% | 6.02M +6.90% | 5.94M +3.98% | 6.39M +9.13% | 5.98M +3.43% | 6.07M +0.90% | 6.02M +1.40% | 6.11M -4.36% | 24.19M -- |
Operating Expenses | 3.87M -- | 3.64M -- | 3.27M -- | 4.99M -- | 3.61M -6.60% | 2.99M -17.91% | 3.45M +5.33% | 6.63M +32.85% | 3.68M +1.99% | 4.24M +41.84% | 4.38M +26.96% | 4.38M -33.94% | 4.07M +10.56% | 4.60M +8.60% | 4.43M +1.19% | 23.01M +425.80% | 4.96M +21.87% | 4.63M +0.54% | 4.55M +2.73% | 6.51M -71.71% | 4.93M -0.73% | 4.58M -1.01% | 4.12M -9.39% | 10.08M +54.77% | 23.71M -- |
Selling, General and Administrative Expenses | 3.91M -- | 3.60M -- | 3.42M -- | 3.53M -- | 3.45M -11.74% | 3.42M -5.17% | 3.76M +10.09% | 4.81M +36.45% | 3.65M +5.78% | 4.19M +22.74% | 3.89M +3.24% | 4.97M +3.25% | 4.16M +13.84% | 4.32M +3.04% | 4.09M +5.16% | 5.73M +15.26% | 4.46M +7.26% | 4.08M -5.62% | 4.36M +6.64% | 6.21M +8.37% | 4.83M +8.26% | 4.45M +9.09% | 4.06M -6.78% | 5.63M -9.24% | 18.97M -- |
Research and Development Expenses | 5.72K -- | 9.82K -- | 1.25K -- | 7.06K -- | 6.19K +8.18% | 3.24K -67.04% | 10.00K +701.60% | 30.44K +331.15% | 147.22K +2278.35% | 80.90K +2399.10% | 80.27K +702.40% | 76.40K +151.00% | 78.83K -46.45% | 304.68K +276.63% | 344.13K +328.71% | 443.81K +480.89% | 502.89K +537.91% | 241.09K -20.87% | 193.93K -43.65% | 304.63K -31.36% | 98.14K -80.48% | 131.71K -45.37% | 61.63K -68.22% | 84.78K -72.17% | 376.26K -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | 1.28M -- | -- -- | -- -- | -- -- | 1.16M -9.32% | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | 0 -- | 16.85M -- | -- -- | 308.00K -- | 0 -- | 0 -100.00% | -- -- | 0 -100.00% | 0 -- | 4.36M -- | -- -- |
Loss on Disposal of Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 15.11K -- | -- -- | -- -- | -- -- | -407.34K -2795.68% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | -51.41K -- | 27.42K -- | -145.75K -- | 169.74K -- | 152.39K +396.42% | -431.60K -1673.86% | -324.90K -122.92% | 604.11K +255.90% | -116.43K -176.40% | -36.10K +91.63% | 412.31K +226.90% | -259.77K -143.00% | -164.70K -41.46% | -23.12K +35.95% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | 1.25M -- | 1.75M -- | 2.48M -- | 239.91K -- | 1.24M -1.11% | 2.00M +13.86% | 1.60M -35.64% | -1.61M -769.41% | 1.47M +19.04% | 1.19M -40.13% | 954.31K -40.22% | 1.25M +177.71% | 1.68M +14.47% | 1.03M -13.94% | 1.28M +34.52% | -17.16M -1475.12% | 821.22K -51.21% | 1.39M +35.38% | 1.39M +8.27% | -122.35K +99.29% | 1.06M +28.59% | 1.49M +7.27% | 1.90M +36.74% | -3.97M -3142.24% | 482.39K -- |
Non-Operating Income (Loss) | -309.72K -- | -418.84K -- | -1.54M -- | 1.59M -- | -282.77K +8.70% | -353.88K +15.51% | -335.11K +78.30% | 362.35K -77.22% | -314.73K -11.30% | -294.59K +16.75% | -313.35K +6.49% | -625.53K -272.63% | -468.64K -48.90% | -681.48K -131.33% | -216.09K +31.04% | 1.17M +286.87% | -26.71K +94.30% | 80.66K +111.84% | -10.03K +95.36% | -720.09K -161.60% | -522.29K -1855.20% | -917.53K -1237.50% | -714.54K -7027.58% | -665.18K +7.62% | -2.82M -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -8.13K -- | -- -- | -- -- | -- -- | -13.06K -60.69% | -- -- | -- -- | -- -- | 407.23K +3217.18% | -- -- | -- -- | 376.12K -- | 14.05K -96.55% | 229.68K -- | 409.80K -- | 522.46K +38.91% | 20.00K +42.33% | -31.40K -113.67% | -379.33K -192.57% | -193.89K -137.11% | -201.65K -1108.29% | -806.27K -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | 1.94M -- | -- -- | -- -- | -- -- | 782.48K -59.67% | -- -- | -- -- | -- -- | -435.33K -155.63% | -- -- | -- -- | -122.67K -- | 985.82K +326.45% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | 55.58K -- | -53.47K -- | -1.21M -- | 133.27K -- | -2.55K -104.59% | -12.49K +76.65% | 761 +100.06% | 14.38K -89.21% | -8.63K -238.42% | -18.07K -44.71% | 52.00K +6733.64% | -23.63K -264.34% | -2.41K +72.05% | -211.53K -1070.62% | 102 -99.80% | 5 +100.02% | 63 +102.61% | 137 +100.06% | 981 +861.76% | 5.40K +107940.00% | 4.07K +6360.32% | 12.93K +9335.77% | 17.57K +1690.52% | 18.41K +240.87% | 52.98K -- |
Net Interest Expense | 365.30K -- | 365.37K -- | 338.68K -- | 474.67K -- | 280.22K -23.29% | 341.39K -6.56% | 335.87K -0.83% | 421.45K -11.21% | 306.10K +9.23% | 276.52K -19.00% | 365.35K +8.78% | 573.80K +36.15% | 466.23K +52.32% | 469.95K +69.95% | 469.64K +28.55% | -169.03K -129.46% | 256.46K -44.99% | 329.27K -29.93% | 533.46K +13.59% | 745.49K +541.04% | 494.96K +93.00% | 551.13K +67.38% | 538.22K +0.89% | 481.95K -35.35% | 2.07M -- |
Interest Expense | 365.30K -- | 365.37K -- | 338.68K -- | 474.67K -- | 280.22K -23.29% | 341.39K -6.56% | 335.87K -0.83% | 421.45K -11.21% | 306.10K +9.23% | 276.52K -19.00% | 365.35K +8.78% | 573.80K +36.15% | 466.23K +52.32% | 469.95K +69.95% | 469.64K +28.55% | -169.03K -129.46% | 256.46K -44.99% | 329.27K -29.93% | 533.46K +13.59% | 745.49K +541.04% | 494.96K +93.00% | 551.13K +67.38% | 538.22K +0.89% | 481.95K -35.35% | 2.07M -- |
Pretax Income From Continuing Operations | 939.35K -- | 1.33M -- | 936.04K -- | 1.83M -- | 952.49K +1.40% | 1.64M +23.09% | 1.26M +34.74% | -1.24M -167.94% | 1.16M +21.33% | 899.78K -45.18% | 640.97K -49.18% | 622.51K +150.05% | 1.21M +5.09% | 346.42K -61.50% | 1.07M +66.56% | -15.99M -2669.13% | 794.51K -34.58% | 1.47M +324.98% | 1.38M +29.25% | -842.43K +94.73% | 533.72K -32.82% | 575.10K -60.94% | 1.19M -14.05% | -4.63M -449.83% | -2.34M -- |
Income Tax Expense | 252.38K -- | 380.01K -- | 151.57K -- | 630.77K -- | 258.90K +2.58% | 470.56K +23.83% | 404.74K +167.03% | -606.49K -196.15% | 323.65K +25.01% | 265.06K -43.67% | 174.15K -56.97% | -215.31K +64.50% | 447.71K +38.33% | 125.44K -52.68% | 387.06K +122.26% | -4.80M -2130.71% | 238.27K -46.78% | 816.39K +550.83% | 328.19K -15.21% | 1.02M +121.22% | 250.86K +5.29% | 219.32K -73.14% | 436.59K +33.03% | -814.54K -179.92% | 92.23K -- |
Net Income | 686.97K -- | 953.34K -- | 784.47K -- | 1.20M -- | 693.59K +0.96% | 1.17M +22.79% | 856.49K +9.18% | -637.19K -153.11% | 832.05K +19.96% | 634.72K -45.78% | 466.82K -45.50% | 837.82K +231.49% | 766.81K -7.84% | 220.98K -65.19% | 680.56K +45.79% | -11.19M -1435.61% | 556.24K -27.46% | 655.79K +196.77% | 1.05M +54.53% | -1.86M +83.36% | 282.86K -49.15% | 355.79K -45.75% | 749.41K -28.74% | -3.82M -105.06% | -2.43M -- |
Net Income Attributable to Owners of the Company | 686.97K -- | 953.34K -- | 784.47K -- | 1.20M -- | 693.59K +0.96% | 1.17M +22.79% | 856.49K +9.18% | -637.19K -153.11% | 832.05K +19.96% | 634.72K -45.78% | 466.82K -45.50% | 837.82K +231.49% | 766.81K -7.84% | 220.98K -65.19% | 680.56K +45.79% | -11.19M -1435.61% | 556.24K -27.46% | 655.79K +196.77% | 1.05M +54.53% | -1.86M +83.36% | 282.86K -49.15% | 355.79K -45.75% | 749.41K -28.74% | -3.82M -105.06% | -2.43M -- |
Net Income Attributable to Common Stockholders | 686.97K -- | 953.34K -- | 784.47K -- | 1.20M -- | 693.59K +0.96% | 1.17M +22.79% | 856.49K +9.18% | -637.19K -153.11% | 832.05K +19.96% | 634.72K -45.78% | 466.82K -45.50% | 837.82K +231.49% | 766.81K -7.84% | 220.98K -65.19% | 680.56K +45.79% | -11.19M -1435.61% | 556.24K -27.46% | 655.79K +196.77% | 1.05M +54.53% | -1.86M +83.36% | 282.86K -49.15% | 355.79K -45.75% | 749.41K -28.74% | -3.82M -105.06% | -2.43M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | -- -- | 3.62M -- | -- -- | -- -- | -- -- | 2.08M -42.52% | -- -- | -- -- | -- -- | 2.77M +33.02% | -- -- | -- -- | 680.56K -- | -11.19M -503.77% | 556.24K -- | 655.79K -- | 1.05M +54.53% | -1.86M +83.36% | 282.86K -49.15% | 355.79K -45.75% | 749.41K -28.74% | -3.82M -105.06% | -2.43M -- |
Basic EPS | 0.09 -- | 0.13 -- | 0.1 -- | -- -- | 0.09 -- | 0.15 +15.38% | 0.1 -- | -0.07 -- | 0.1 +11.11% | 0.08 -46.67% | 0.06 -40.00% | 0.1 +242.86% | 0.09 -10.00% | 0.03 -62.50% | 0.08 +33.33% | -1.35 -1450.00% | 0.07 -22.22% | 0.08 +166.67% | 0.13 +62.50% | -0.23 +82.96% | 0.03 -57.14% | 0.04 -50.00% | 0.09 -30.77% | -0.47 -104.35% | -0.31 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0.08 -- | -- -- | 0.07 -- | 0.08 -- | 0.13 +62.50% | -- -- | 0.03 -57.14% | 0.04 -50.00% | 0.09 -30.77% | -- -- | -- -- |
Diluted EPS | 0.08 -- | 0.12 -- | 0.1 -- | -- -- | 0.08 -- | 0.14 +16.67% | 0.1 -- | -- -- | 0.1 +25.00% | 0.07 -50.00% | 0.06 -40.00% | -- -- | 0.09 -10.00% | 0.03 -57.14% | 0.08 +33.33% | -- -- | 0.07 -22.22% | 0.08 +166.67% | 0.13 +62.50% | -- -- | 0.03 -57.14% | 0.04 -50.00% | 0.09 -30.77% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0.08 -- | -- -- | 0.07 -- | 0.08 -- | 0.13 +62.50% | -- -- | 0.03 -57.14% | 0.04 -50.00% | 0.09 -30.77% | -- -- | -- -- |
You can ask Aime
What were the key takeaways from Cryo-Cell's earnings call?What factors drove the changes in Cryo-Cell's revenue and profit?What guidance did Cryo-Cell's management provide for the next earnings period?What is Cryo-Cell's gross profit margin?What is the revenue and EPS growth rate for Cryo-Cell year over year?What were the key takeaways from Cryo-Cell’s earnings call?What is Cryo-Cell's latest dividend and current dividend yield?Did Cryo-Cell beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
